250 filings
Page 4 of 13
8-K
hvlau2hewen ww
10 Jan 22
Results of Operations and Financial Condition
7:00am
8-K
oa3so 84ey0
21 Dec 21
Departure of Directors or Certain Officers
4:30pm
8-K
lf4eyjgg
20 Dec 21
Cara Therapeutics Announces CMS Grants TDAPA to KORSUVA™ (difelikefalin) Injection
7:00am
8-K
pjglm5x bl
8 Nov 21
Cara Therapeutics Reports Third Quarter 2021 Financial Results
4:10pm
8-K
trmlv7v hf3ijgyzdy
3 Nov 21
Cara Therapeutics Announces CEO Transition
8:10am
8-K
t01l0 13jv1z
31 Aug 21
Other Events
12:00am
8-K
rerf11w6bzw yu
23 Aug 21
Other Events
4:44pm
8-K
pgobxuhz ow321h
12 Aug 21
Regulation FD Disclosure
8:03am
8-K
eyav5
9 Aug 21
Cara Therapeutics Reports Second Quarter 2021 Financial Results
4:10pm
8-K
lxkzoz mchdy
4 Aug 21
Entry into a Material Definitive Agreement
12:00am
8-K
17o07u 26bkzdr4m
7 Jun 21
Submission of Matters to a Vote of Security Holders
4:35pm
8-K
4u4q7nlg
10 May 21
Cara Therapeutics Reports First Quarter 2021 Financial Results
4:10pm
8-K
fusoufcy
29 Apr 21
Cara Therapeutics Announces Topline Results From
7:21am
DEFA14A
xw8l apgotds
23 Apr 21
Additional proxy soliciting materials
4:33pm
8-K
5ybge5d
30 Mar 21
VFMCRP and Cara Therapeutics announce European Medicines Agency has accepted to review the Marketing Authorization Application for difelikefalin
6:01am
8-K
pam6 snojob591wgltrq
8 Mar 21
Regulation FD Disclosure
8:38am